Company / Operating Income per Share
Edwards Lifesciences Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.18
FY2025
5-year range
$2.18 / $2.78
FY2021-FY2025
Trend
-5.1%
vs FY2024
Sector context
#66 of 154
Health Care
What the data says
At $2.18, Edwards Lifesciences's operating income per share ranks #66 of 154 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $1.44 in FY2020 to $5.48 in FY2019.
Based on SEC 10-K filings.
2.18 in FY2025 with a 5-year CAGR of +8.7%.
Declined from $2.78 to $2.18 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -4.0%
- 5-Year CAGR
- +8.7%
- 10-Year CAGR
- -
Sector benchmark
#66 of 154 in Health CareTop 43% of 154This company $2.18 Sector average $4.29
▼
-49.2% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 5.1% year-over-year.
- Ranks #66 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.18 | -5.1% |
| FY2024 | $2.29 | -17.5% |
| FY2023 | $2.78 | +12.8% |
| FY2022 | $2.46 | -9.1% |
| FY2021 | $2.71 | +88.4% |
| FY2020 | $1.44 | -73.8% |
| FY2019 | $5.48 | +52.2% |
| FY2018 | $3.60 | -30.0% |
| FY2017 | $5.15 | +45.0% |
| FY2016 | $3.55 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026